Combination, use of 9,10-dihydro-5-methoxy-9-oxo-n- 4- 2- (1,2,3,4-tetrahydro-6,7-dimethoxy-2-iso quinolinyl) -ethyl -phenyl -4-acridine-carboxamide or a salt thereof, and process for increasing bioavailability in oral administration to a mammalian patient of a pharmacologically active agent

摘要

"COMBINATION, USE OF 9,10-DI-HYDRO-5-METOXY-9-OXO-N- [4- [2- (1,2,3,4-TETRA-HYDRO- 6,7-DIMEThoXY-2- ISOQUINOLINIL) -ETHYL] -FENIL] -4-ACRIDINE-CARBOXAMIDE OR ITS SALT, AND PROCESS TO INCREASE BIOAVAILABILITY IN ORAL ADMINISTRATION TO A MAMMALIAN PATIENT OF AN ACTIVE PHARMACOLOGICALLY AGENT ". A combination of 9,10-dihydro-5-methoxy-9-oxo-N- [4- [2- (1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl) -ethyl] -phenyl] -4-acridine-carboxamide or a salt and paclitaxel and analogs or derivatives thereof.